AlphaBeta AB
6Patents
5Active
6Granted
39Portfolio score
Filing activity: Nov 19, 2001 → Jan 16, 2015 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8785391B2 | Compound and method for treatment of alzheimer's disease and familial dementia | Human Necessities | 3 | Active |
| US8785390B2 | Methods for treatment of Alzheimer's disease | Human Necessities | 2 | Active |
| US10023610B2 | Ligands for prevention of neurotoxicity of the alzheimer's disease related amyloid-beta peptide | Physics | 0 | Active |
| US6716589B2 | Discordant helix stabilization for prevention of amyloid formation | Physics | 0 | Expired |
| US9580460B2 | Discordant helix stabilization for prevention of amyloid formation | Physics | 0 | Active |
| US9522170B2 | Methods of screening compounds for the fibril formation of Aβ peptides based on a decreased trimer/monomer ratio of a chaperone protein | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.